Trial of CPX-351 in Adult Patients With First Relapse Acute Myeloid Leukemia (AML)

Clinical trial NCT00822094 · COMPLETED

Trial details

NCT number: NCT00822094
Sponsor: Jazz Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2009-02-01
Primary completion: 2011-12-01
Enrollment: 126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.